SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001072613-18-000093
Filing Date
2018-02-08
Accepted
2018-02-08 11:53:29
Documents
1
Group Members
COREY GOODMANROBERT ADELMANVENBIO GLOBAL STRATEGIC GP II, L.P.VENBIO GLOBAL STRATEGIC GP II, LTD.

Document Format Files

Seq Description Document Type Size
1 VENBIO GLOBAL STRATEGIC FUND II, L.P. - MENLO THERAPEUTICS INC. -- SCHEDULE 13D menlo13d_18163.htm SC 13D 195868
  Complete submission text file 0001072613-18-000093.txt   197741
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Subject) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90268 | Film No.: 18583982
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund II L.P. (Filed by) CIK: 0001634632 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D